[HTML][HTML] Tertiary lymphoid structures and B cells: An intratumoral immunity cycle
WH Fridman, M Meylan, G Pupier, A Calvez… - Immunity, 2023 - cell.com
The generation of anti-tumor immunity in the draining lymph nodes is known as the cancer
immunity cycle. Accumulating evidence supports the occurrence of such a cycle at tumor …
immunity cycle. Accumulating evidence supports the occurrence of such a cycle at tumor …
The effect of physical exercise on anticancer immunity
C Fiuza-Luces, PL Valenzuela, BG Gálvez… - Nature Reviews …, 2024 - nature.com
Regular physical activity is associated with lower cancer incidence and mortality, as well as
with a lower rate of tumour recurrence. The epidemiological evidence is supported by …
with a lower rate of tumour recurrence. The epidemiological evidence is supported by …
Role of B cells in immune‐related adverse events following checkpoint blockade
KM Dhodapkar, A Duffy… - Immunological Reviews, 2023 - Wiley Online Library
Blockade of immune checkpoints has transformed the therapy of several cancers. However,
immune‐related adverse events (irAEs) have emerged as a major challenge limiting the …
immune‐related adverse events (irAEs) have emerged as a major challenge limiting the …
[HTML][HTML] Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
J Bao, AC Betzler, J Hess, C Brunner - Frontiers in Immunology, 2023 - frontiersin.org
In the tumor milieu of head and neck squamous cell carcinoma (HNSCC), distinct B cell
subpopulations are present, which exert either pro-or anti-tumor activities. Multiple factors …
subpopulations are present, which exert either pro-or anti-tumor activities. Multiple factors …
A blueprint for tumor-infiltrating B cells across human cancers
J Ma, Y Wu, L Ma, X Yang, T Zhang, G Song, T Li… - Science, 2024 - science.org
B lymphocytes are essential mediators of humoral immunity and play multiple roles in
human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell …
human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell …
[HTML][HTML] Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Y Zhang, M Xu, Y Ren, Y Ba, S Liu, A Zuo, H Xu… - Molecular Cancer, 2024 - Springer
Tertiary lymphoid structures (TLS) are clusters of immune cells that resemble and function
similarly to secondary lymphoid organs (SLOs). While TLS is generally associated with an …
similarly to secondary lymphoid organs (SLOs). While TLS is generally associated with an …
[HTML][HTML] Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
L Esparcia-Pinedo, N Romero-Laorden… - Frontiers in …, 2023 - frontiersin.org
Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells with an organization that
resembles that of secondary lymphoid organs. Both structures share common …
resembles that of secondary lymphoid organs. Both structures share common …
[HTML][HTML] Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity
To mount an effective anti-tumor immune response capable of controlling or eliminating
disease, sufficient numbers of lymphocytes must be recruited to malignant tissue and …
disease, sufficient numbers of lymphocytes must be recruited to malignant tissue and …
[HTML][HTML] A noninvasive approach to evaluate tumor immune microenvironment and predict outcomes in hepatocellular carcinoma
J Wu, W Liu, X Qiu, J Li, K Song, S Shen, L Huo… - Phenomics, 2023 - Springer
It is widely recognized that tumor immune microenvironment (TIME) plays a crucial role in
tumor progression, metastasis, and therapeutic response. Despite several noninvasive …
tumor progression, metastasis, and therapeutic response. Despite several noninvasive …
[HTML][HTML] Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing
F Jia, S Sun, J Li, W Wang, H Huang, X Hu, S Pan… - Cancer Letters, 2024 - Elsevier
Hormone receptor-positive breast cancer (HR+ BC) is known to be relatively insensitive to
chemotherapy, and since chemotherapy has remained the major neoadjuvant therapy for …
chemotherapy, and since chemotherapy has remained the major neoadjuvant therapy for …